<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shiau S</submitter><funding>NIA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><funding>National Institute on Aging</funding><pagination>1982-1991</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8664485</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>73(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Accelerated epigenetic aging using DNA methylation (DNAm)-based biomarkers has been reported in people with human immunodeficiency virus (HIV, PWH), but limited data are available among African Americans (AA), women, and older PWH.&lt;h4>Methods&lt;/h4>DNAm was measured using Illumina EPIC Arrays for 107 (69 PWH and 38 HIV-seronegative controls) AA adults ≥60 years in New York City. Six DNAm-based biomarkers of aging were estimated: (1) epigenetic age acceleration (EAA), (2) extrinsic epigenetic age acceleration (EEAA), (3) intrinsic epigenetic age acceleration (IEAA), (4) GrimAge, (5) PhenoAge, and (6) DNAm-estimated telomere length (DNAm-TL). The National Institutes of Health (NIH) Toolbox Cognition Battery (domains: executive function, attention, working memory, processing </pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pubmed_title>Epigenetic Aging Biomarkers Associated With Cognitive Impairment in Older African American Adults With Human Immunodeficiency Virus (HIV).</pubmed_title><pmcid>PMC8664485</pmcid><funding_grant_id>R21 AG056175</funding_grant_id><funding_grant_id>R25 MH108389</funding_grant_id><pubmed_authors>Yin MT</pubmed_authors><pubmed_authors>Arpadi SM</pubmed_authors><pubmed_authors>Jang G</pubmed_authors><pubmed_authors>Brickman AM</pubmed_authors><pubmed_authors>Shiau S</pubmed_authors><pubmed_authors>Baccarelli AA</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors><pubmed_authors>Manly JJ</pubmed_authors><pubmed_authors>Ramon CV</pubmed_authors><pubmed_authors>Cantos A</pubmed_authors><pubmed_authors>Shah J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic Aging Biomarkers Associated With Cognitive Impairment in Older African American Adults With Human Immunodeficiency Virus (HIV).</name><description>&lt;h4>Background&lt;/h4>Accelerated epigenetic aging using DNA methylation (DNAm)-based biomarkers has been reported in people with human immunodeficiency virus (HIV, PWH), but limited data are available among African Americans (AA), women, and older PWH.&lt;h4>Methods&lt;/h4>DNAm was measured using Illumina EPIC Arrays for 107 (69 PWH and 38 HIV-seronegative controls) AA adults ≥60 years in New York City. Six DNAm-based biomarkers of aging were estimated: (1) epigenetic age acceleration (EAA), (2) extrinsic epigenetic age acceleration (EEAA), (3) intrinsic epigenetic age acceleration (IEAA), (4) GrimAge, (5) PhenoAge, and (6) DNAm-estimated telomere length (DNAm-TL). The National Institutes of Health (NIH) Toolbox Cognition Battery (domains: executive function, attention, working memory, processing </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-22T06:49:42.78Z</modification><creation>2025-04-05T21:54:56.606Z</creation></dates><accession>S-EPMC8664485</accession><cross_references><pubmed>34143869</pubmed><doi>10.1093/cid/ciab563</doi></cross_references></HashMap>